2011
DOI: 10.1016/s2173-5727(11)70015-7
|View full text |Cite
|
Sign up to set email alerts
|

Effect of the administration of statins in non-cardiac critical disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2011
2011
2011
2011

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 85 publications
0
1
0
Order By: Relevance
“…These treatments, in 10-20% of patients, fail to normalize the hemodynamics of patients with septic shock, existing high probability that the cardiac output was diminished by SIMD. There is no known way to mitigate the SIMD, although it begins to consider the need to study the administration of a cardioprotective therapy to critically ill patients, which could have a special role for beta-blockers, inhibitors of the enzyme converting (ACE) inhibitors, calcium channel blockers and statins [ 196 ]. Nor is there consensus for the treatment of diastolic dysfunction in the SIMD, although the evidence in similar circumstances such as heart failure, also suggests that ACE inhibitors, antagonists of angiotensin-II receptor, and beta blockers have a potential benefit [ 197 ].…”
Section: Treatmentmentioning
confidence: 99%
“…These treatments, in 10-20% of patients, fail to normalize the hemodynamics of patients with septic shock, existing high probability that the cardiac output was diminished by SIMD. There is no known way to mitigate the SIMD, although it begins to consider the need to study the administration of a cardioprotective therapy to critically ill patients, which could have a special role for beta-blockers, inhibitors of the enzyme converting (ACE) inhibitors, calcium channel blockers and statins [ 196 ]. Nor is there consensus for the treatment of diastolic dysfunction in the SIMD, although the evidence in similar circumstances such as heart failure, also suggests that ACE inhibitors, antagonists of angiotensin-II receptor, and beta blockers have a potential benefit [ 197 ].…”
Section: Treatmentmentioning
confidence: 99%